289 related articles for article (PubMed ID: 32882043)
1. Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.
Maloney KM; Le Guillou A; Driggers RA; Sarkar S; Anderson EJ; Malik AA; Jenness SM
J Infect Dis; 2021 Jan; 223(1):72-82. PubMed ID: 32882043
[TBL] [Abstract][Full Text] [Related]
2. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
[TBL] [Abstract][Full Text] [Related]
3. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
4. Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons.
Okafor CN; Eaton L; Watson R
AIDS Behav; 2024 Jun; 28(6):2166-2174. PubMed ID: 38526639
[TBL] [Abstract][Full Text] [Related]
5. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
[TBL] [Abstract][Full Text] [Related]
6. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
7. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
Parsons JT; Rendina HJ; Whitfield TH; Grov C
AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
[TBL] [Abstract][Full Text] [Related]
8. Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.
Meyers K; Wu Y; Qian H; Sandfort T; Huang X; Xu J; Zhang J; Xia W; Glidden D; Wu H; Shang H
AIDS Behav; 2018 Apr; 22(4):1217-1227. PubMed ID: 28707025
[TBL] [Abstract][Full Text] [Related]
9. Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men.
Patel RR; Crane JS; López J; Chan PA; Liu AY; Tooba R; James AS
PLoS One; 2018; 13(12):e0209484. PubMed ID: 30592756
[TBL] [Abstract][Full Text] [Related]
10. Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.
Balasubramanian R; Kasaie P; Schnure M; Dowdy DW; Shah M; Fojo AT
J Acquir Immune Defic Syndr; 2022 Oct; 91(2):144-150. PubMed ID: 35636746
[TBL] [Abstract][Full Text] [Related]
11. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
12. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
[TBL] [Abstract][Full Text] [Related]
13. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
[TBL] [Abstract][Full Text] [Related]
14. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
[TBL] [Abstract][Full Text] [Related]
15. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
Glaubius RL; Hood G; Penrose KJ; Parikh UM; Mellors JW; Bendavid E; Abbas UL
Clin Infect Dis; 2016 Aug; 63(4):539-47. PubMed ID: 27193745
[TBL] [Abstract][Full Text] [Related]
17. Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study.
Goodreau SM; Hamilton DT; Jenness SM; Sullivan PS; Valencia RK; Wang LY; Dunville RL; Barrios LC; Rosenberg ES
J Adolesc Health; 2018 Mar; 62(3):311-319. PubMed ID: 29248392
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.
Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES
Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
Jenness SM; Goodreau SM; Rosenberg E; Beylerian EN; Hoover KW; Smith DK; Sullivan P
J Infect Dis; 2016 Dec; 214(12):1800-1807. PubMed ID: 27418048
[TBL] [Abstract][Full Text] [Related]
20. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]